← All Sponsors

SPONSOR

Arcturus Therapeutics, Inc.

Total Trials

1

Recruiting

1

Phases

Phase 2

Conditions studied: OTC Deficiency Ornithine Transcarbamylase Deficiency OTCD

NCT06488313 Phase 2

A Study to Evaluate the Pharmacodynamics and Safety of ARCT-810 in Participants With OTCD